As of 2025-10-22, the Relative Valuation of Vertex Pharmaceuticals Inc (VRTX) is 79.17 USD. This relative valuation is based on P/E multiples. With the latest stock price at 426.27 USD, the upside of Vertex Pharmaceuticals Inc based on Relative Valuation is -81.4%.
The range of the Relative Valuation is 68.92 - 148.58 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 61.2x - 131.9x | 70.3x |
| Fair Price | 68.92 - 148.58 | 79.17 |
| Upside | -83.8% - -65.1% | -81.4% |
| Date | P/E |